Bank of New York Mellon Corp lowered its stake in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 3.9% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 357,823 shares of the specialty chemicals company’s stock after selling 14,368 shares during the period. Bank of New York Mellon Corp owned approximately 1.83% of Innophos worth $17,601,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in IPHS. Old Mutual Global Investors UK Ltd. acquired a new position in shares of Innophos during the third quarter valued at about $109,000. Public Employees Retirement System of Ohio raised its position in shares of Innophos by 5.9% during the second quarter. Public Employees Retirement System of Ohio now owns 2,824 shares of the specialty chemicals company’s stock valued at $124,000 after buying an additional 157 shares during the last quarter. Pacad Investment Ltd. raised its position in shares of Innophos by 19.5% during the second quarter. Pacad Investment Ltd. now owns 4,900 shares of the specialty chemicals company’s stock valued at $215,000 after buying an additional 800 shares during the last quarter. Ifrah Financial Services Inc. acquired a new position in Innophos in the third quarter worth about $215,000. Finally, GHP Investment Advisors Inc. raised its position in Innophos by 35.5% in the second quarter. GHP Investment Advisors Inc. now owns 5,599 shares of the specialty chemicals company’s stock worth $245,000 after purchasing an additional 1,468 shares in the last quarter. 94.46% of the stock is owned by institutional investors and hedge funds.

Innophos Holdings, Inc. (IPHS) opened at $44.91 on Monday. Innophos Holdings, Inc. has a 52-week low of $41.66 and a 52-week high of $58.22. The company has a debt-to-equity ratio of 0.83, a current ratio of 2.86 and a quick ratio of 1.49. The stock has a market cap of $877.05, a PE ratio of 18.26 and a beta of 0.86.

Innophos (NASDAQ:IPHS) last posted its quarterly earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.72 by $0.06. Innophos had a net margin of 6.19% and a return on equity of 13.90%. The firm had revenue of $184.00 million during the quarter, compared to analyst estimates of $179.33 million. During the same quarter in the prior year, the business posted $0.69 earnings per share. The company’s quarterly revenue was down 1.1% compared to the same quarter last year. analysts expect that Innophos Holdings, Inc. will post 2.5 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Investors of record on Friday, November 17th were given a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 4.28%. The ex-dividend date of this dividend was Thursday, November 16th. Innophos’s dividend payout ratio (DPR) is presently 88.48%.

Several research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Innophos from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of Innophos in a research report on Wednesday, November 1st. Finally, BidaskClub lowered shares of Innophos from a “hold” rating to a “sell” rating in a research report on Tuesday, December 5th.

COPYRIGHT VIOLATION NOTICE: This report was first reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.watchlistnews.com/innophos-holdings-inc-iphs-shares-sold-by-bank-of-new-york-mellon-corp/1770762.html.

Innophos Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).

Institutional Ownership by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.